Hearing On Kings Arena A "Formality" Packers Set For Shareholders' Meeting Coverage Of Boston's Nixed '24 Bid Meeting On Chargers Stadium Today NFL Cardinals Have Female Assistant Coach Charlotte Commits $600,000 For NBA ASG Bucks Arena Funding Heads To Assembly NFL Hosting Activation Summit USOC, Boston End '24 Games Bid Sabres Part Ways With Ted Black
MLB, MLBPA Announce Significant Changes To Drug Testing Policy
Published January 10, 2013
"I can't emphasize enough when I think all that has gone on relative to steroids, when you think of where we were, this is a proud day, a great day for baseball," said MLB Commissioner Bud Selig, speaking following owners' meetings in Paradise Valley, Ariz. "We'll continue to be a leader in this field and do what we have to do."
Read the full story.
"The players, and [Weiner] in particular showed real leadership on this issue, and are to be commended," said MLB Exec VP/Economics & League Affairs Rob Manfred. "Having an individual baseline for each player, we think is going to be a lot more accurate and a lot more powerful in terms of the detection." The longitudinal profile program for player testosterone levels will be maintained by the Montreal Laboratory, a facility accredited by WADA.
The news of the drug policy changes just a day after the Baseball Writers Association of America failed to elect a player this year to the Baseball HOF, in large part due to marked voter division over steroids, was coincidental as the shifts have been in negotiation for months. But Selig added the timing "wasn't too bad, though, was it." Added Weiner today in a statement, "I believe these changes firmly support the players' desires while protecting their legal rights."
U.S. Rep. Henry Waxman (D-Calif.), a long-time watchdog on baseball's testing policy, applauded the changes in a statement saying, "Baseball can rightly boast that it has the best testing program among our country's professional major leagues."